about
Transcriptional adaptations following exercise in thoroughbred horse skeletal muscle highlights molecular mechanisms that lead to muscle hypertrophyTwenty-five years since the discovery of endothelium-derived relaxing factor (EDRF): does a dysfunctional endothelium contribute to the development of type 2 diabetes?Hypoglycemic effects and mechanisms of electroacupuncture on insulin resistanceInsulin resistance is associated with diminished endoplasmic reticulum stress responses in adipose tissue of healthy and diabetic subjectsDisordered lipid metabolism and the pathogenesis of insulin resistance.Metabolic impact of body fat distribution.Serum glycine is associated with regional body fat and insulin resistance in functionally-limited older adultsObesity, insulin resistance and free fatty acids.Pharmacotherapy for dyslipidaemia--current therapies and future agents.Chronic Kidney Disease in Non-Diabetic Older Adults: Associated Roles of the Metabolic Syndrome, Inflammation, and Insulin Resistance.Insulin sensitivity and secretory status of a healthy malay population.Should nonalcoholic fatty liver disease be renamed?Association of adiposity, cardiorespiratory fitness and exercise practice with the prevalence of type 2 diabetes in Brazilian elderly women.Assessment of insulin sensitivity/resistance.Dioscorea Extract (DA-9801) Modulates Markers of Peripheral Neuropathy in Type 2 Diabetic db/db Mice.Ganglioside GM3 as a gatekeeper of obesity-associated insulin resistance: Evidence and mechanisms.Protective role of physical activity on type 2 diabetes: Analysis of effect modification by race-ethnicity.The role of mouse Akt2 in insulin-dependent suppression of adipocyte lipolysis in vivoA futile metabolic cycle activated in adipocytes by antidiabetic agents.Standard isolation of primary adipose cells from mouse epididymal fat pads induces inflammatory mediators and down-regulates adipocyte genes.Identification of genes contributing to the obese yellow Avy phenotype: caloric restriction, genotype, diet x genotype interactions.
P2860
Q21283740-9DF65CB2-C8F6-4793-A098-ADA25FB89C7EQ30352122-EBE24104-74AF-4438-9D11-DEBF36A0D307Q34001606-0B244D43-1162-4A9F-B61A-A0032CC43D65Q34077404-71BD011F-B595-47E5-BD41-4728E9ED0C7CQ34370965-849AECD1-D90B-407C-93C0-E9C6DD425935Q35037257-67FE407C-CF55-4C97-8291-C4C109E938E4Q35082745-30D8B431-7126-470E-BB2C-ED03229BAC39Q35204838-F6EC3E26-B970-4907-9BB2-354310FB4FB0Q35574960-B694C929-B08F-437C-A74D-94FE1EC45593Q35796995-1B42F019-9F55-449E-A962-1DA4EDA902C6Q35950688-819608E3-6B8C-4B66-A1AF-4DAF4823523AQ36141458-4FA183FD-3ACD-4ECD-958A-4B99F674D6DDQ36174163-EF169402-9A29-4514-A544-A62A979B31F8Q38320413-7357F09F-32C1-4984-9DA7-15C0D503EFCEQ38431815-51799F0B-D846-426E-9083-738C016E08A6Q38598747-98A5342C-5B64-4B20-8E0F-832FB8300FA8Q39330066-28012716-2565-4F1C-B889-3394911FAC07Q39530992-44DB3058-6E2B-4C42-A6A4-BFF772C1DDE7Q40700524-61C5A28C-DA8F-4BA1-AF66-4B578DF0AA0AQ42795938-84944EC7-CB98-41E3-B92A-8438A22E3D02Q46207304-E31B4C79-88C3-4538-8E02-3F39ED9BC770
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Pathogenesis of type 2 diabetes. Insulin resistance.
@ast
Pathogenesis of type 2 diabetes. Insulin resistance.
@en
Pathogenesis of type 2 diabetes. Insulin resistance.
@nl
type
label
Pathogenesis of type 2 diabetes. Insulin resistance.
@ast
Pathogenesis of type 2 diabetes. Insulin resistance.
@en
Pathogenesis of type 2 diabetes. Insulin resistance.
@nl
prefLabel
Pathogenesis of type 2 diabetes. Insulin resistance.
@ast
Pathogenesis of type 2 diabetes. Insulin resistance.
@en
Pathogenesis of type 2 diabetes. Insulin resistance.
@nl
P1476
Pathogenesis of type 2 diabetes. Insulin resistance.
@en
P2093
P304
P356
10.1016/S0889-8529(05)70216-4
P577
2001-12-01T00:00:00Z